GDMT in Heart Failure - The Power of Pills: Opportunities and Challenges (Michelle Kittleson, MD)

The talk will cover optimal guideline-directed medical therapy in heart failure with reduced ejection fraction, the pitfalls in clinical trial interpretation, and practical tips for implementation.
Objectives:
1. Identify optimal guideline-directed medical therapy for heart failure with reduced ejection fraction.
2. Describe pitfalls to clinical trials of GDMT in HF
3. Determine a strategy for the implementation of GDMT
#Houstonmethodist #debakeycveducation #heartfailure #reducedejectionfraction
** This medical education program may contain graphic content. **
_________________________________
A DeBakey CV Education event
Presented by Houston Methodist DeBakey Heart & Vascular Center.
Building on Dr. Michael E. DeBakey’s commitment to excellence in education, Houston Methodist DeBakey CV Education is an epicenter for cardiovascular academic and clinical educational programs that support the provision of optimal care to patients suffering from cardiovascular conditions and diseases.
FOR MORE INFORMATION
DeBakey CV Education:
www.houstonmethodist.org/educ...
For the latest education and training opportunities from DeBakey CV Education: bit.ly/HMdebakeyemail
Follow Us:
Twitter: / debakeycvedu
Livestream: livestream.com/debakey
SmugMug: debakey.smugmug.com/
Want concise, relevant reviews of the hottest topics in CV medicine? Subscribe for FREE to the Methodist DeBakey Cardiovascular Journal for quarterly, peer-reviewed issues delivered to your door.
journal.houstonmethodist.org/

Пікірлер: 1

  • @ghulamqadir9138
    @ghulamqadir9138Ай бұрын

    How we can titrate quadruple therapy if there is HFimpEF, let it to be continued as quadruple or priorities drugs which is to be stopped or titrated ?